Tami Reller
Known title: DirectorCIK: 0001582737
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Stifel Keeps Hold Rating on SPS Commerce, Up Target to $85. Stifel has kept its hold rating on SPS Commerce while lifting its price target to $85. The new target sits above the current consensus average of $75.45 and near the top of the 52‑week range. The rating suggests the brokerage sees no immediate upside or downside. The stock is trading with an RSI of 57.3 and a revenue‑price divergence signal over the past year.
Transaction History
| HCAT | ▲ Buy | Grant | 128,851 | $0 | 10/1/2026 | View on chart |
| SPSC | ▲ Buy | Grant | 3,736 | $0 | 5/28/2026 | View on chart |
| SPSC | ▲ Buy | Option Exercise | 5,732 | $297K | 3/13/2026 | View on chart |
| SPSC | ▲ Buy | Grant | 1,310 | $0 | 5/13/2025 | View on chart |
| SPSC | ▲ Buy | Option Exercise | 6,570 | $245K | 3/26/2025 | View on chart |
| SPSC | ▲ Buy | Grant | 465 | $0 | 5/16/2024 | View on chart |
| SPSC | ▲ Buy | Option Exercise | 6,052 | $176K | 5/14/2024 | View on chart |
| SPSC | ▲ Buy | Grant | 585 | $0 | 5/12/2023 | View on chart |
| SPSC | ▲ Buy | Option Exercise | 6,792 | $178K | 3/6/2023 | View on chart |
| SPSC | ▲ Buy | Option Exercise | 13,142 | $344K | 3/6/2023 | View on chart |
| SPSC | ▲ Buy | Grant | 838 | $0 | 5/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.